49 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
INVESTOR CONTACT:
Tim McCarthy
LifeSci Advisors
tim@lifesciadvisors.com
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
INVESTOR CONTACT:
Tim McCarthy
LifeSci
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
Exhibit Index
Exhibit
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
Affiliates or Permitted Sublicensees (licensee with respect to Licensor), directly or indirectly, commences any action, claim, motion, petition, litigation
6-K
v95pt q6573sxa9
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.2
c44qwx hro94e
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
5n423b1se80yj7
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
gjqwpj
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
my1we6xu v55pdg53
5 Jun 23
Current report (foreign)
4:28pm
6-K
7rvxa
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
0pq9wo 18o
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
e489cwql0asr 9gx5ty0
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
6-K
z25t19y 6tzeowqq
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
EX-99.1
mhxsrv hi0jp4qx
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
c4k7bi6du 74begm217
4 Oct 22
Current report (foreign)
7:16am
6-K
kdcm79v j3qsnf
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
EX-99.1
2lwlysud1oeh
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
cf17stixacwmzp sb
11 Jul 22
Current report (foreign)
4:30pm